Cited by 59Nanoplatforms for cancer theranosticsGlioma Diagnosis and TreatmentNanoparticle-Based Drug Delivery

In Situ Formation of Nanotheranostics to Overcome the Blood–Brain Barrier and Enhance Treatment of Orthotopic Glioma

Gao, Haiyan, Chu, Chengchao, Cheng, Yi, Zhang, Yang, Pang, Xin, Li, Dengfeng, Wang, Xiaoyong, Ren, En +5 more·2020·ACS Applied Materials & Interfaces

Abstract

Glioblastoma is one of the most lethal cancers and needs effective therapeutics. The development of coordination-driven metal–organic nanoassemblies, which can cross the blood–brain barrier (BBB) and blood–brain tumor barrier (BBTB) and have multiple desired functions, may provide a promising solution to this issue. Here, we report an in situ assembled nanoplatform based on RGD peptide-modified bisulfite-zinc II -dipicolylamine-Arg-Gly-Asp (Bis(DPA-Zn)-RGD) and ultrasmall Au-ICG nanoparticles. Attributed to its positive charges and neovascular targeting properties, Bis(DPA-Zn)-RGD can be selectively delivered to the tumor site, and then assembled in situ into large nanoclusters with subsequently administered Au-ICG nanoparticles. Au nanoparticles with ultrasmall size (∼7 nm) can successfully cross the BBB. The obtained nanoclusters exhibit strong near-infrared-red (NIR) absorption and an enhanced tumor retention effect, enabling precise orthotopic fluorescence/photoacoustic imaging. With the aid of image guidance, the photothermal effect of the nanoclusters is observed to suppress tumor progression with the inhibition efficiency reaching up to 93.9%. Meanwhile, no photothermal damage can be found for normal brain tissues. These results, herein, suggest a feasible nanotheranostic agent with the ability to overcome the BBB and BBTB for imaging and therapy of orthotopic brain tumors.

Integrity signals

Registry

Crossref · 10.1021/acsami.0c03873

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Gao et al. used RGD polypeptide to modify Bis(DPA-Zn)-RGD, which can be selectively delivered to tumor sites due to RGD's new blood vessel targeting properties.

    “Gao et al. used RGD polypeptide to modify bisulfite-zincII-dipicolylamine (Bis(DPA-Zn)-RGD). Due to the new blood vessel targeting properties of RGD, Bis(DPA-Zn)-RGD can be selectively delivered to tumor sites.”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [218]

  • The R/Au-ICG nanoclusters can penetrate the blood-brain barrier and inhibit the growth of brain tumors in mice.

    “The newly developed gold nanoclusters can penetrate the blood-brain barrier and use its high photothermal effect to inhibit the growth of brain tumors in mice.218”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [218]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gao, H., Chu, C., Cheng, Y., Zhang, Y., Pang, X., Li, D., Wang, X., Ren, E., Xie, F., Bai, Y., Chen, L., Liu, G., & Wang, M.
Affiliations
  • Zhengzhou University (CN)
  • Xiamen University (CN)
Corresponding author
  • Liu, Gang
  • Wang, Meiyun
Venue
ACS Applied Materials & Interfaces
Published
2020-05-22
Volume
12
Issue
24
Pages
26880-26892
ISSN
  • 1944-8244 (ISSN-L)
  • 1944-8252
OpenAlex
W3026950172
Cited by
59
References
68
Citations by year
2026: 4 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 17 · 2021: 10
FWCI
2.98
Type
journal article
Language
en
Open access
closed
Locations
  • ACS Applied Materials & Interfaces (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education of the People's Republic of China (20720190088)
  • Ministry of Science and Technology of the People's Republic of China (2017YFA0205201, 2017YFE0103600, 2018YFA0107301)
  • National Natural Science Foundation of China (31470047, 81422023, 81603015, 81641168, 81720108021, 81772009, 81871404, U1505221, U1705281)
  • Henan Province (182102310162)
  • Zhongyuan Thousand Talents Plan Project - Basic Research Leader Talent (ZYQR201810117)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
glioblastoma, blood-brain barrier, blood-brain tumor barrier, nanotheranostics, zinc coordination, RGD peptide, dipicolylamine, gold nanoparticles, indocyanine green, photothermal therapy, near-infrared fluorescence imaging, photoacoustic imaging, tumor targeting
MeSH terms
Theranostic Nanomedicine, Animals, Blood-Brain Barrier, Glioma, Gold, Humans, Metal Nanoparticles, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review